Fundraising FoxFemTherapeutics
5 known investors
Find your way into FemTherapeutics
Sign up to see every warm intro you have to FemTherapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the FemTherapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
FemTherapeutics develops treatment solutions for pelvic organ prolapse (POP), a condition affecting women who have had a vaginal delivery. The company aims to improve on existing options such as poorly fitting pessaries and invasive surgery.
Investors · 5
How we know: 2048 Ventures's portfolio page · a partner's Signal profile · funding news · betakit.com · the VCSheet dataset · Not right? Tell us
How we know: SheBoot's portfolio page · funding news · betakit.com · Not right? Tell us
How we know: The 51 Ventures's portfolio page · Not right? Tell us
How we know: funding news · betakit.com · Not right? Tell us
Also in the syndicate · 1
Funding
SEC filings, press & company announcements$1.9M disclosed across 1 of 2 rounds · 2023
- $1.9MraisedJun 2023 · 2 sources
2048 Ventures (lead), Investissement Quebec, Sheboot, The51 Ventures
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does FemTherapeutics do?
- FemTherapeutics develops treatment solutions for pelvic organ prolapse (POP), a condition affecting women who have had a vaginal delivery. The company aims to improve on existing options such as poorly fitting pessaries and invasive surgery.
- Who are FemTherapeutics's investors?
- FemTherapeutics's investors include 2048 Ventures, SheBoot, The 51 Ventures, Investissement Quebec.
- How much funding has FemTherapeutics raised?
- FemTherapeutics has disclosed $1.9M raised across 1 of its 2 known rounds.